Clinical features of drug-induced hypersensitivity syndrome in 38 patients

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 7, 2010, Pages 556-562

  Um, S J ^a   Lee, S K ^a   Kim, Y H ^a   Kim, K H ^a   Son, C H ^a   Roh, M S ^a   Lee, M K ^b  

^a Dong A University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Anticonvulsant; Corticosteroid; Drug hypersensitivity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; BETA LACTAM ANTIBIOTIC; BILIRUBIN; CARBAMAZEPINE; CEFACLOR; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CORTICOSTEROID; DICLOFENAC; ETHAMBUTOL; IBUPROFEN; ISONIAZID; LAMOTRIGINE; LITHIUM; MOXIFLOXACIN; NAFCILLIN; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PHENOBARBITAL; PHENYTOIN; PYRAZINAMIDE; RIFAMPICIN; RISPERIDONE; TAZOBACTAM; ZONISAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DRESS SYNDROME; DRUG MEGADOSE; EOSINOPHIL COUNT; FATALITY; FEMALE; HUMAN; LIVER FAILURE; LIVER INJURY; LYMPHOCYTE COUNT; MALE; OPPORTUNISTIC INFECTION; PROGNOSIS; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; DRUG HYPERSENSITIVITY; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 79251486696     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): A reaction induced by complex interplay among herpes viruses and antiviral and antidrug immune responses. Allergol Int. 2006;55:1-8.
2. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250-7.
3. Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D, Network of the French pharmacovigilance centers. Variability in the clinical pattern of cutaneous sideeffects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155:422-8.
4. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083-4.
5. Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med. 1950;242:897-8.
6. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997;49:542-6.
7. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 1995;155:2285-90.
8. Tas S, Simonart T. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Clin Belg. 1999;54:197-200.
9. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology. 2005;209:123-9.
10. Ganeva M, Gancheva T, Lazarova R, Troeva J, Baldaranov I, Vassilev I, Hristakieva E, Tzaneva V. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol. 2008;47:853-60.
11. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother. 1993;27:337-43.
12. Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multi-organ failure. Arch Dermatol. 2009;145:67-72.
13. Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, Hu S, Hong HS, Chung WH. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22:1044-9.
14. Ben m'rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, Guesmi M, Rollot F, Dehoux M, Guillevin L, Moachon L. Drug-induced hypersensitivity syndrome clinical and biologic disease patterns in 24 patients. Medicine (Baltimore). 2009;88:131-40.
15. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K, Pichler WJ, Demoly P, ENDA, EAACI. Diagnosis of nonimmediate reactions to ß-lactam antibiotics. Allergy. 2004;59:1153-60.
16. Tchen T, Reguai Z, Vitry F, Arnoult E, Grange A, Florent G, Bernard P. Usefulness of skin testing in cutaneous drug eruptions in routine practice. Contact Dermatitis. 2009;61:138-44.
17. Devos SA, Van Der Valk PG. Epicutaneous patch testing. Eur J Dermatol. 2002;12:506-13.
18. Suswardana, Hernanto M, Yundani BA, Pudjiati SR, Indrastuti N. DRESS syndrome from cephadroxyl confirmed by positive patch test. Allergy. 2007;62:1216-7.
19. Akcam FZ, Ayqun FO, Akkaya VB. DRESS like severe drug rash with eosinophilia, atypic lymphocytosis and fever secondary to ceftriaxone. J Infect. 2006;53:51-3.
20. Son CH, Kim HI, Kim KN, Lee KN, Lee CU, Roh MS, Kim KH, Yang DK, Lee SK. Moxifloxacin-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis. J Investig Allergol Clin Immunol. 2008;18:72-3.
21. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: What is the pathogenesis? Arch Dermatol. 2001;137:357-64.
22. Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007;48:1015-8.
23. Bocquet H, Bagot M, Roujeau JC. DIDMOHS: A proposed consensus nomenclature for the drug-induced multiorgan hypersensitivity syndrome. Arch Dermatol. 1998;134:875.
24. Kaminsky A, Moreno M, Diaz M, Charas V, Bravo G, Kien C. Anticonvulsant hypersensitivity syndrome. Int J Dermatol. 2005;44:594-8.
25. Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, Morel P, Dubertret L, Avril MF, Revuz J. Druginduced pseudolymphoma and hypersensitivity syndrome: Two different clinical entities. Arch Dermatol. 1996;132:1315-21.
26. Kim YH, Lee CU, Kim KH, Kim SH, Shin BC, Seo HR, Kim BK, Heo JH, Yang DK, Lee SK, Son CH. Rhabdomyolysis as a manifestation of phenytoin-induced anticonvulsant hypersensitivity syndrome. Korean J Asthma Allergy Clin Immunol. 2007;27:66-9 [Article in Korean].
27. Gupta A, Eggo M, Uetrecht JP, Cribb AE, Danemon D, Rieder MJ, Shear NH, Cannon M, Spilberg SP. Drug-induced hypothyroidism; The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther. 1992;51:56-67.
28. Sommers LM, Schoene RB. Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and newonset diabetes mellitus. Arch Intern Med. 2002;162:1190-2.
29. Aota N, Hirahara K, Kano Y, Fukuoka T, Yamada A, Shoihara T. Systemic lupus erythematosus presenting with Kikuchi- Fujimoto's disease as a long-term sequela of drug-induced hypersensitivity syndrome. Dermatology. 2009;218:275-7.
30. Sakuma K, Kano Y, Fukuhara M, Shiohara T. Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome. Clin and Exp Deramtol. 2007;33:287-90.
31. Roujeau JC. Treatment of severe drug eruptions. J Dermatol. 1999;26:718-22.
32. Hellman C, Lönnkvist K, Hedlin G, Hallden G, Lundahl J. Down-regulated IL-5 receptor expression in peripheral blood eosinophil from budesonide-treated children with asthma. Allergy. 2002;57:323-8.
33. De Vries A, Philippe J, Van Renterghem D, De Cuyper CA, Hindryckx PH, Matthys EG, Louagie A. Carbamazepine hypersensitivity syndrome: Report of 4 cases and review of the literature. Medicine. 1995;74:144-51.
34. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Saraux JL, Grange MJ, Grossin M, Navratil E, Crickx B, Belaich S. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol. 1997;137:605-8.